Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

HGS Europe

Market access opportunities in China

Pope Woodhead highlights the key steps to accessing the high-value therapeutics market in China

Novartis building

NICE backs Novartis’ Tobi Podhaler in cystic fibrosis

But draft guidance doesn't recommend Forest’s Colobreathe

Think differently about digital strategy

Why the change to digital communications means we need a different strategic approach

- PMLiVE

Ireland forges drug pricing pact with pharma

Could cut drug bill by €400m

- PMLiVE

Data-driven pharma marketing

The most successful organisations of the future will be the ones that are able to ride the ‘data tsunami’ to gain a competitive advantage – and understanding data generated by...

- PMLiVE

NICE and ABPI clash over access to medicines

Trade body says research shows medicines underused but NICE claims new figures 'higher than expected'

- PMLiVE

Are you really listening or just waiting to speak?

A modern social listening programme can indentify people’s motivations and information needs

Open Health adds pH Associates to its roster

UK real world data specialist will bolster Open's market access offering

The problem with targeting a healthcare message

A well-designed digital experience should account for all the different ways in which people look for information

Pharma must ’embrace the new reality’ and meet payers’ needs

This means capturing better health economic data during product development, says Takeda's Trevor Smith

- PMLiVE

Knowledge is power

The value of an educational approach in achieving clinical engagement with pharma marketing campaigns

- PMLiVE

Patient access schemes likely to remain under VBP, says NICE

New and existing schemes expected to have place within UK’s new pricing environment

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links